Combination was uncovered from examining 12 potential drug candidates with over 530,0000 possible drug combinations within two weeks Credit: National University of Singapore A team of...
On Wall Street, it’s out with tech and mega-caps and in with small-caps, cyclicals and value. Investors have been rotating away from the big names that...
As Eli Lilly continues to build out data for their FDA-authorized Covid-19 treatment bamlanivimab, they’ve been seeking new partners to conduct more trials. And the pharma...
Once touted as promising treatments and by some even a cure, the World Health Organization dashes those claims, finding no benefit in the use of four popular Covid-19 treatments (remdesivir, hydroxychloroquine, lopinavir, or interferon-beta-1a)...
Initial studies suggest these drugs, widely taken to lower cholesterol, may also reduce the severity of COVID-19.
This is what it's like fighting COVID-19 the second time around.
Generally, companies in the healthcare sector show resilience amid challenging macro conditions. However, certain healthcare stocks have been under pressure during the pandemic due to supply...
CNBC Exclusive: CNBC Transcript: Oncolmmune Founder and CEO Dr. Yang Liu speaks with CNBC’s “Squawk Box” today, discussing Oncolmmune being acquired by Merck. Q3 2020 hedge...
WHO says Gilead’s remdesivir should not be used in hospitalized Covid-19 patients
US Tops Off Worst Week Yet With Record 180k New COVID-19 Cases: Live Updates
Lilly’s baricitinib granted US emergency use in COVID-19
Eli Lilly Arthritis Drug Gets Emergency Green-Light As COVID-19 Treatment
WHO Officially Counsels Against Prescribing Gilead's Remdesivir To Treat COVID-19
FDA Grants EUA to Combination of Olumiant and Remdesivir in Hospitalized Covid-19 Patients
Covid-19 roundup: EU begins reviewing Moderna vaccine; CureVac and EU agree to 405M-dose deal
Promising results from in vitro combination therapy against COVID-19
What monoclonal antibodies are – and why we need them as well as a vaccine
World’s top intensive care body advises against remdesivir for sickest Covid patients
Treatments for people with early COVID-19 infection is an urgent research focus
Exclusive: WHO-led Covid drug scheme doubles down on antibodies, steroids and shuns remdesivir
U.S. has plan to start Pfizer vaccine shots in December: CNBC
Lilly to ship COVID-19 drug straight away after FDA green light
Aspirin to be tested as potential Covid-19 drug in UK study
Humanigen Spikes 13% On Positive Covid-19 Data For Lenzilumab
COVID-19 drug and vaccine patents are putting profit before people
The ‘failure’ of clinical trials in the search for COVID-19 treatments
Death rates have fallen by 18% for hospitalized COVID–19 patients as treatments improve
Should investors spend more time considering the upside risks?
Oppenheimer’s Leland Gershell on the Future of Biopharma
Covid-19 roundup: Russian biotech seeks permission to produce remdesivir generic; Why did BARDA fund plasma company part-owned by Rick Santorum?